Physician profile
Tim D Johnson
NPI 1437181351
$1,516.65
in general payments reported to CMS, 2019-2025
13 companies · $163 in 2025
The $163 reported for 2025 was less than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $570 · 2020: $264 · 2021: $45.68 · 2022: $117 · 2023: $269 · 2024: $88.20 · 2025: $163.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $520.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $519.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $824.98 | 2019-2025 | Hydrus Microstent, Rocklatan |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $132.40 | 2019-2021 | |
| Aerie Pharmaceuticals, INC. | $119.68 | 2019-2020 | |
| Glaukos Corporation | $101.24 | 2019-2023 | |
| Rxsight INC | $59.79 | 2023-2024 | Rxsight Injector Handpiece, Rxsight Light Delivery Device (Ldd), Rxsight Contact Lens |
| Allergan, INC. | $57.98 | 2019-2022 | |
| Omeros Corporation | $56.62 | 2019 | |
| New World Medical,INC. | $54.50 | 2023 | |
| Johnson & Johnson Surgical Vision, INC. | $27.83 | 2023 | Tecnis Iol |
| Amgen INC. | $24.36 | 2024 | Tepezza |
| Abbvie INC. | $23.49 | 2024 | |
| Ivantis, INC | $17.32 | 2019 | |
| Oyster Point Pharma, INC. | $16.46 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tim Johnson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.